Skip to main content

Health Technology Assessment and Market Access

The fourth Innovation Day Taguspark is scheduled for October 24 and is dedicated to the theme "Health Technology Assessment and Market Access".

With the presence of experts in the field, this event focuses on three points:

  • The role of Health Technology Assessment (HTA) in Access to Therapeutic Innovation
  • Access to Therapeutic Innovation in Portugal: main challenges
  • Market access in Europe: Similarities and contrasts between EU countries

With free admission, but subject to reservation, the Innovation Day includes a series of meetings/debates that, from the Panoramic Restaurant (floor 4 of the Taguspark Central Nucleus), aim to explore the technological scenario in the startup areas of the Taguspark Incubator.

Program

17H0 - 19H00

Welcome

Eduardo Baptista Correia, CEO Taguspark

Speakers

Francisco Batel Marques, Co-Founder Clevidence

Telma Costa, Scientific Affairs & Pharma Business Development Director

Alicia de Castro Aguirre, Portugal Country Manager Eli Lilly

Debate

"Health Technology Assessment and Market Access

Questions & Answers

Networking & Cocktails

Health technology assessment and market access

The fourth Taguspark Innovation Day is scheduled for October 24th and is dedicated to the theme of "Health technology assessment and market access".

With the presence of experts in the field, this event focuses on three points:

  • The role of Health Technology Assessment (HTA) in Access to Therapeutic Innovation
  • Access to Therapeutic Innovation in Portugal: main challenges
  • Market access in Europe: Similarities and contrasts between EU countries

With free admission, but subject to reservation, Innovation Day includes a series of meetings/debates which, from the Panoramic Restaurant (floor 4 of the Taguspark Central Center), aim to explore the technological scenario in the areas of the Taguspark Incubator startups.

Program

17H0 - 19H00

Welcome

Eduardo Baptista Correia, CEO Taguspark

Speakers

Francisco Batel Marques, Co-Founder Clevidence

Telma Costa, Scientific Affairs & Pharma Business Development Director

Alicia de Castro Aguirre, Portugal Country Manager Eli Lilly

Debate

"Health technology assessment and market access"

Questions and answers

Networking & Cocktails

Privacy Preference Center